Literature DB >> 18805456

Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.

Katrin S Kohl1, Manya Magnus, Robert Ball, Neal Halsey, Sean Shadomy, Thomas A Farley.   

Abstract

We evaluated the applicability, reliability, sensitivity, and specificity of six standardized case definitions for adverse events following immunization (AEFI) (for fever, generalized convulsive seizure, hypotonic-hyporesponsive episode, intussusception, nodule, and persistent crying) developed by the Brighton Collaboration using the U.S. Vaccine Adverse Event Reporting System (VAERS). The evaluation included: (a) the development of codified search strings using standardized coding terminology, and (b) for sensitivity and specificity analyses, the development of a "gold standard" for case determination by clinical expert reviews, and its comparison against the application of the definitions to VAERS reports by nonclinicians. Application of the case definitions in an automated approach proved to be valid, feasible, and unlikely to miss confirmed cases of the reported clinical event. The definitions had variable but generally high sensitivity and specificity compared to clinician review, which in itself yielded inconsistent case determination. The study demonstrated the need for the developed standardized definitions for AEFI and their usefulness in passive surveillance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805456     DOI: 10.1016/j.vaccine.2008.09.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.

Authors:  Rohit P Ojha; Bradford E Jackson; Joseph E Tota; Tabatha N Offutt-Powell; Karan P Singh; Sejong Bae
Journal:  Hum Vaccin Immunother       Date:  2013-09-06       Impact factor: 3.452

2.  Automating case definitions using literature-based reasoning.

Authors:  T Botsis; R Ball
Journal:  Appl Clin Inform       Date:  2013-10-30       Impact factor: 2.342

Review 3.  Management for intussusception in children.

Authors:  Steven Gluckman; Jonathan Karpelowsky; Angela C Webster; Richard G McGee
Journal:  Cochrane Database Syst Rev       Date:  2017-06-01

Review 4.  Safety assessment of adjuvanted vaccines: Methodological considerations.

Authors:  Fernanda Tavares Da Silva; Alberta Di Pasquale; Juan P Yarzabal; Nathalie Garçon
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Treatment Outcome of Acute Intussusception in Children Under Two Years of Age: A Prospective Cohort Study.

Authors:  Nguyen Thanh Xuan; Nguyen Huu Son; Ho Huu Thien
Journal:  Cureus       Date:  2020-04-18

Review 6.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03

7.  Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.

Authors:  Jiayao Lei; Madhava Ram Balakrishnan; Jane F Gidudu; Patrick L F Zuber
Journal:  Vaccine       Date:  2018-02-14       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.